UTESCH v. LANNETT COMPANY, INC. et al

  1. March 16, 2026

    Lannett Investors Seek Final OK Of $5.8M Price-Fix Probe Suit

    Former executives of pharmaceutical company Lannett Inc. and a class of investors have asked a Pennsylvania federal court to grant final approval to their $5.8 million deal to end claims the company and its leadership misled about Lannett's links to allegations of industrywide price-fixing in the market for generic drugs.

  2. August 12, 2021

    Lannett Investors Nab Cert. In Suit Over Price-Fix Probes

    A Pennsylvania federal judge signed off on class certification Thursday in a case accusing Lannett Co. Inc. of artificially inflating its stock price by misleading investors about its links to allegations of industrywide price-fixing in the market for generic drugs.